Io Biotech Stock Probability Of Bankruptcy

IOBT Stock  USD 0.90  0.01  1.12%   
IO Biotech's chance of distress is under 21% at this time. It has slight odds of undergoing some form of financial trouble in the near future. Probability of financial unrest prediction helps decision makers evaluate IO Biotech's chance of financial distress in relation to its going-concern outlook and evaluation. All items used in analyzing the odds of distress are taken from the IOBT balance sheet, as well as cash flow and income statements available from the company's most recent filings. Check out IO Biotech Piotroski F Score and IO Biotech Altman Z Score analysis.
For more information on how to buy IOBT Stock please use our How to Invest in IO Biotech guide.
  
Market Cap is likely to drop to about 72.4 M in 2024. Enterprise Value is likely to gain to about (80.3 M) in 2024

IO Biotech Company probability of financial unrest Analysis

IO Biotech's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Probability Of Bankruptcy

 = 

Normalized

Z-Score

More About Probability Of Bankruptcy | All Equity Analysis

Current IO Biotech Probability Of Bankruptcy

    
  Less than 21%  
Most of IO Biotech's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, IO Biotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of IO Biotech probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting IO Biotech odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of IO Biotech financial health.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IO Biotech. If investors know IOBT will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IO Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.29)
Return On Assets
(0.51)
Return On Equity
(0.88)
The market value of IO Biotech is measured differently than its book value, which is the value of IOBT that is recorded on the company's balance sheet. Investors also form their own opinion of IO Biotech's value that differs from its market value or its book value, called intrinsic value, which is IO Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IO Biotech's market value can be influenced by many factors that don't directly affect IO Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IO Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if IO Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IO Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

IOBT Probability Of Bankruptcy Driver Correlations

Understanding the fundamental principles of building solid financial models for IO Biotech is extremely important. It helps to project a fair market value of IOBT Stock properly, considering its historical fundamentals such as Probability Of Bankruptcy. Since IO Biotech's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of IO Biotech's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of IO Biotech's interrelated accounts and indicators.
1.00.99-0.42-0.99-0.790.970.64-0.971.0-0.421.00.491.0-0.810.490.65-0.42
1.01.0-0.41-0.99-0.780.980.63-0.971.0-0.411.00.481.0-0.80.480.65-0.41
0.991.0-0.39-0.98-0.790.980.6-0.960.99-0.390.990.540.99-0.790.540.68-0.39
-0.42-0.41-0.390.520.81-0.470.230.45-0.41.0-0.42-0.65-0.410.51-0.65-0.571.0
-0.99-0.99-0.980.520.83-0.96-0.60.96-0.990.52-0.99-0.5-0.990.84-0.5-0.650.52
-0.79-0.78-0.790.810.83-0.86-0.080.79-0.770.81-0.78-0.78-0.770.79-0.78-0.90.81
0.970.980.98-0.47-0.96-0.860.48-0.980.98-0.470.970.570.97-0.780.570.79-0.47
0.640.630.60.23-0.6-0.080.48-0.510.630.230.64-0.230.66-0.54-0.23-0.060.23
-0.97-0.97-0.960.450.960.79-0.98-0.51-0.980.45-0.97-0.45-0.960.69-0.45-0.690.45
1.01.00.99-0.4-0.99-0.770.980.63-0.98-0.41.00.471.0-0.780.470.64-0.4
-0.42-0.41-0.391.00.520.81-0.470.230.45-0.4-0.42-0.65-0.410.51-0.65-0.571.0
1.01.00.99-0.42-0.99-0.780.970.64-0.971.0-0.420.481.0-0.810.480.64-0.42
0.490.480.54-0.65-0.5-0.780.57-0.23-0.450.47-0.650.480.46-0.491.00.77-0.65
1.01.00.99-0.41-0.99-0.770.970.66-0.961.0-0.411.00.46-0.820.460.63-0.41
-0.81-0.8-0.790.510.840.79-0.78-0.540.69-0.780.51-0.81-0.49-0.82-0.49-0.670.51
0.490.480.54-0.65-0.5-0.780.57-0.23-0.450.47-0.650.481.00.46-0.490.77-0.65
0.650.650.68-0.57-0.65-0.90.79-0.06-0.690.64-0.570.640.770.63-0.670.77-0.57
-0.42-0.41-0.391.00.520.81-0.470.230.45-0.41.0-0.42-0.65-0.410.51-0.65-0.57
Click cells to compare fundamentals
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
Competition

Based on the latest financial disclosure, IO Biotech has a Probability Of Bankruptcy of 21.0%. This is 51.49% lower than that of the Biotechnology sector and 61.71% lower than that of the Health Care industry. The probability of bankruptcy for all United States stocks is 47.28% higher than that of the company.

IOBT Probability Of Bankruptcy Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses IO Biotech's direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of IO Biotech could also be used in its relative valuation, which is a method of valuing IO Biotech by comparing valuation metrics of similar companies.
IO Biotech is currently under evaluation in probability of bankruptcy category among its peers.

IOBT Fundamentals

About IO Biotech Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze IO Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of IO Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of IO Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for IOBT Stock Analysis

When running IO Biotech's price analysis, check to measure IO Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IO Biotech is operating at the current time. Most of IO Biotech's value examination focuses on studying past and present price action to predict the probability of IO Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IO Biotech's price. Additionally, you may evaluate how the addition of IO Biotech to your portfolios can decrease your overall portfolio volatility.